Aidspan, an independent watchdog of the Global Fund, on Wednesday published Issue 192 of its “Global Fund Observer.” The issue features an article examining new reports released by the Office of the Inspector General on three audits and four diagnostic reviews; an article highlighting two reports on the impact of the cancellation of Round 11 by the Global Fund; and an article discussing the reaction to Spain’s Global Fund contribution, among others (8/15).
Programs, Funding & Financing
“Kenya’s government, under the leadership of President Mwai Kibaki, has allocated additional funding to its national AIDS response,” UNAIDS reports in a feature story on its webpage, noting, “The announcement came last Friday during a high level advocacy meeting in Nairobi.” “President Kibaki stressed in the meeting that despite a scarcity of resources in Kenya, the Government will not waver in its commitment to the national AIDS response,” UNAIDS writes, adding, “More than 85 percent of resources for Kenya’s response to HIV currently come from development partners” (8/15).
“Having just returned to New York from Maputo, the capital of Mozambique, I’m reminded how lucky we are in this city to have reliable water and sanitation services,” David Winder, chief executive of WaterAid USA, writes this post in Huffington Post’s “Impact” blog. “Increased investment in providing access to safe water and improved sanitation dramatically impacts child survival,” but “[i]n low-income areas of cities like Maputo, that is often a complex task,” he notes. “Often in low-income urban neighborhoods, the provision of piped water to homes is simply too expensive for ordinary families to afford,” he continues.
Haitian Government Hires Former Clinton Administration Official To Discuss Cholera Epidemic With Members Of U.S. Congress
“The Haitian government has hired a one-time Clinton administration official seeking to influence U.S. officials who pledged $3 billion after a 2010 earthquake devastated the impoverished nation’s capital,” the Associated Press/Washington Post reports. “Walter Corley, a former U.S. trade official, said Wednesday that he has been focusing on efforts to stem a cholera outbreak since he was hired by Haiti in April on a one-year contract that pays $5,000 a month,” the news service writes. According to AP, “Corley said he has discussed the cholera epidemic with members of Congressional Black Caucus, including Democratic Reps. John Conyers of Michigan and Maxine Waters of California” (8/15).
“The developing world needs support for low-tech health innovations that do not compromise on effectiveness,” journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, “a new movement of ‘frugal science’ is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries.” Shetty writes, “Cost is rarely the only limiting factor; health technologies need to be ‘low-tech’ — as electricity supplies can be erratic, or hospital environments not always sterile, for instance — without being ‘low-spec,'” and continues, “Achieving this balance requires innovative thinking, which is why researchers from around the world are developing an evidence base for the most effective and innovative healthcare technologies for poorer countries.”
In this post in Huffington Post’s “Healthy Living” blog, John-Manuel Andriote, a journalist and author living with HIV, writes, “For all of us living with HIV infection — Oct. 27 will mark seven years since my own diagnosis — the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?” Reflecting on the XIX International AIDS Conference (AIDS 2012) that took place in Washington last month, he continues, “An AIDS-free generation is certainly a worthy goal,” but “even if tens of billions of additional dollars are allocated to address HIV/AIDS, even if the Republicans don’t succeed in inflicting their Darwinian ‘survival of the fittest’ upon the nation and the world, the question will continue to be what it has been for 31 years … Will we have the political will to end AIDS?”
India on Monday “opened a $12 million, government-backed laboratory whose mission is to create a new vaccine against HIV,” Science Insider reports. “The HIV Vaccine Translational Research Laboratory, which aims to recruit about 30 scientists, is embedded within the Translational Health Science and Technology Institute, a $200 million facility under development on the outskirts of New Delhi” and “will work in collaboration with the New York based-International AIDS Vaccine Initiative (IAVI),” the news service writes, noting “operating costs will be shared equally” (Bagla, 8/14). “Former president A.P.J. Abdul Kalam launched the [laboratory] in New Delhi on Monday at a symposium on accelerating India’s search for an HIV vaccine,” the Wall Street Journal’s livemint.com writes. “Promising ‘strong political will’ at the highest level, health minister Ghulam Nabi Azad said, ‘A preventive vaccine for HIV/AIDS is the best hope to end this epidemic,'” and “added that the step was an initiative to reinforce a national response in the global fight against disease,” the news service notes (Krishnan, 8/13).
“The U.N.’s World Food Programme [WFP] said Tuesday it needs $48 million in food aid for about 11 percent of Malawi’s population who will face hunger due to bad crops,” Agence France-Presse reports. “‘It is estimated that those needing food assistance in the southern African country will rise to 1.6 million people during the peak of the lean season early next year,’ the WFP said in a joint statement with Britain’s Department for International Development (DFID),” the news service writes.
“Scientists researching the lethal Ebola virus have told [BBC News] that a commercial vaccine to prevent the onset of infection may never be developed,” the news service reports. “Efforts to develop a vaccine have been funded in the main by the U.S. Department of Defense and the National Institutes of Health,” which “have poured millions of dollars into scientific research because of concerns that the virus could be turned into a biological weapon,” the news service writes. But in recent days, two companies that had begun human safety trials of their vaccines, Sarepta and Tekmira, “have been told by the Defense Department to temporarily stop work on their vaccines due to funding constraints.”
This post in the Center for Global Development’s (CGD) “Views from the Center” blog, Owen Barder, a senior fellow and the director for Europe at CGD, addresses the recent hunger summit in London, citing two reasons for concern surrounding the discussion. “First, it is wrong to conflate the problem of hunger with the need to improve agricultural productivity. Hunger has very little to do with food production,” Barder writes, continuing, “Second, the conversation is too much about money and not enough about what we should do to address the structural causes of hunger and malnutrition.” He concludes, “If the [G8] leaders cannot get together and make meaningful decisions about something as important as this, why do they bother meeting at all?” (8/13).